DIPRIVAN® (Propofol) Injectable Emulsion, USP is a sterile, nonpyrogenic emulsion containing 10 mg/mL of propofol suitable for intravenous administration.
DIPRIVAN Injectable Emulsion is an IV sedative-hypnotic agent that can be used as described in the table below.
Table 3. Indications for DIPRIVAN Injectable Emulsion
Approved Patient Population
Initiation and maintenance of Monitored Anesthesia Care (MAC) sedation
Combined sedation and regional anesthesia
Adults only (see
Induction of General Anesthesia
Patients ≥ 3 years of age
Maintenance of General Anesthesia
Patients ≥ 2 months of age
Intensive Care Unit (ICU) sedation of intubated, mechanically ventilated patients
Safety, effectiveness and dosing guidelines for DIPRIVAN Injectable Emulsion have not been established for MAC Sedation in the pediatric population; therefore, it is not recommended for this use (see
DIPRIVAN Injectable Emulsion is not recommended for induction of anesthesia below the age of 3 years or for maintenance of anesthesia below the age of 2 months because its safety and effectiveness have not been established in those populations.
In the Intensive Care Unit (ICU), DIPRIVAN Injectable Emulsion can be administered to intubated, mechanically ventilated adult patients to provide continuous sedation and control of stress responses only by persons skilled in the medical management of critically ill patients and trained in cardiovascular resuscitation and airway management.
DIPRIVAN Injectable Emulsion is not indicated for use in Pediatric ICU sedation since the safety of this regimen has not been established (see
DIPRIVAN Injectable Emulsion is not recommended for obstetrics, including Cesarean section deliveries. DIPRIVAN Injectable Emulsion crosses the placenta, and as with other general anesthetic agents, the administration of DIPRIVAN Injectable Emulsion may be associated with neonatal depression (see
DIPRIVAN Injectable Emulsion is not recommended for use in nursing mothers because propofol has been reported to be excreted in human milk, and the effects of oral absorption of small amounts of propofol are not known (see
Published Studies Related to Diprivan (Propofol)
Electroconvulsive therapy pre-treatment with low dose propofol: comparison with
unmodified treatment. 
CONCLUSION: Whilst unmodified ECT should never be used when modified ECT under
Cisatracurium pretreatment with tourniquet reduces propofol injection pain: a
double-blind randomized controlled trial. 
with that of lidocaine... CONCLUSIONS: 0.15 mg/kg cisatracurium effectively decreases the incidence and
Comparison of dexmedetomidine and propofol for conscious sedation in awake
craniotomy: a prospective, double-blind, randomized, and controlled clinical
sedation in awake craniotomy... CONCLUSIONS: Either DEX or PRO can be effectively and safely used for conscious
Reducing the pain of microemulsion propofol injections: a double-blind,
randomized study of three methods of tourniquet and lidocaine. 
of tourniquet application and lidocaine administration on MP injection pain... CONCLUSIONS: We concluded that intravenous retention of lidocaine with the
Ketofol (mixture of ketamine and propofol) administration in electroconvulsive
The aim of this study was to evaluate the effect of a ketamine:propofol
combination ('ketofol') for electroconvulsive therapy on seizure activity,
haemodynamic response and recovery parameters, and to compare with these with the
effects of propofol alone...
Clinical Trials Related to Diprivan (Propofol)
Comparison of Different Propofol Formulations [Recruiting]
The objective of this study is to evaluate the influence of different propofol
formulations(plain or with lidocaine)on anesthetic induction. Propofol plain or with
lidocaine is administered using a closed-loop algorithm in order to reach a Bispectral Index
target of 50.
Propofol Versus Propofol-Fentanyl as Sedation For Lumbar Puncture in Children With Acute Leukemia/Lymphoma [Completed]
The hypothesis of the study is that propofol-fentanyl sedation for lumbar punctures in
children with acute leukemia/lymphoma results in fewer adverse events than propofol sedation
alone. Secondary hypotheses state that propofol-fentanyl sedation results in a better
sedation induction, recovery profile and is preferred by patients/families. The study is a
double blind, randomized, placebo controlled crossover study. Following the induction phase
of chemotherapy, children will be randomized in a crossover manner to receive either
fentanyl-propofol or propofol-placebo for future lumbar punctures. Patients will be studied
on two separate occasions, once with propofol-placebo (normal saline) and once with
propofol-fentanyl. Children will be monitored continuously by pulse oximetry,
electrocardiogram (ECG) and direct nursing and physician observation during the sedation in
accordance with the University of Wisconsin (UW) Pediatric Policy and Procedure. Propofol
will be titrated to a Children's Hospital of Eastern Ontario Pain Scale (CHEOPS) score of ≤ 7
for all children. Oxygen saturation, respiratory rate, heart rate and blood pressure will be
recorded every 3 minutes by a study investigator during sedation.
Compare Pharmaco-economics and Efficacy of Sevoflurane With Low Fresh Gas Flow Balanced Anesthesia, Propofol Target Controlled Infusion Anesthesia and Propofol Induction Sevoflurane Maintenance Anesthesia [Not yet recruiting]
This study is performed to demonstrate that the direct anesthetic costs of a low fresh gas
flow balanced sevoflurane anesthesia for elective laparoscopy are less compared to the
direct anesthetic costs of a target-controlled infusion anesthesia based on propofol.
A Comparison of Ketofol (Ketamine and Propofol Admixture) Versus Propofol as Induction Agents on Hemodynamic Parameters [Recruiting]
This is a pilot study to compare the hemodynamic changes that occur during induction with a
novel drug combination known as ketofol (propofol and ketamine admixture with that of
propofol alone (prototypic anesthesia induction agent). Propofol and ketamine are widely
used as induction agents and their effects on patient hemodynamics are well known. Some of
these drug-induced hemodynamic changes are undesirable and lead to deleterious effects on
patient hemodynamics. We seek to investigate the hemodynamic changes associated with a
novel drug combination known as ketofol (ketamine/propofol admixture) during induction and
compare them to propofol. If we determine that the changes produced by ketofol are
favorable compared with propofol, we then will seek to test its use in the trauma setting in
a subsequent randomized controlled trial.
COGNITIVE - Cognitive Function After Sevoflurane or Propofol Anesthesia for Open-Heart Operations [Suspended]
The aim of the study is to prove if general anesthesia with inhaled sevoflurane reduces the
frequency of neurological and cognitive impairment after open-heart operations with use of
cardiopulmonary by-pass (CPB) in comparison with intravenous anesthesia with propofol.
Reports of Suspected Diprivan (Propofol) Side Effects
Anaphylactic Shock (73),
Cardiac Arrest (14),
Circulatory Collapse (12),
Blood Pressure Decreased (11),
Tachycardia (10), more >>
Page last updated: 2014-11-30